Pharma Reviews: Wrong to say USFDA has been unduly harsh on Indian pharma: Piramal

The USFDA has strong reasons for most of the actions against the Indian pharma industry, says Ajay Piramal, Chairman, Piramal Group . Excerpts ...
Read more: Wrong to say USFDA has been unduly harsh on Indian pharma: Piramal